Linear relationship between Simpson’s Diversity and SST. حسب Rebecca J. Ward (9872202)

الموضوعات:

Future research directions. حسب Martha R. Smith (20410184)

الموضوعات:

Linear regression of PCS score. حسب Le Dai Minh (14295271)

الموضوعات:

Linear regression of MCS score. حسب Le Dai Minh (14295271)

الموضوعات:

Increasing gaps and decreasing returns attenuate spending effects. حسب William Minozzi (8564712)

الموضوعات:

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

The results of linear mixed model. حسب Soheila Qanbari (20455173)

الموضوعات:

Summary of significance levels for comparison of surgical segment ROM between different test groups. حسب Jia Zhu (135506)

الموضوعات:

Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data. حسب Soheila Qanbari (20455173)

الموضوعات:

Heat map of the significance coefficients of PH components and PAB time in children, controlling for age, by gender (blue for boys, red for girls). حسب Xin Xiong (113595)

الموضوعات:

Comparative analysis of δ¹³C and δ¹⁵N isotopes in camelid bone and fiber using Generalized Linear and Linear Mixed Effects Models. حسب Sarah J. Noe (19846136)

الموضوعات:

Forest plots showing a significant improvement in the LVEDD in the experiment group compared with the control group. حسب Ziyi Li (349831)

الموضوعات:

Forest plots showing a significant improvement in the LVESD in the experiment group compared with the control group. حسب Ziyi Li (349831)

الموضوعات: